Leadership Team

Board of Directors

Tim Edwards

Tim joined Karus as Executive Chair in Q2 2019, after a transitional period as non-executive. He has extensive management and advisory experience in the biopharmaceutical industry. As well as his role at Karus, Tim is a Director of AstronauTX Limited, a company developing new medicines to reset the behaviour of astrocytes in the brain, founded by The Dementia Discovery Fund; and Non-executive Chair of Storm Therapeutics Limited, a pioneer in the field of RNA epigenetics. read more

Ron Hunt

Ron Hunt is a Managing Director at New Leaf Venture Partners and focuses on early to late stage investments in biopharmaceuticals. Ron was one of the founders of New Leaf in 2005, and today has over two decades of experience investing in and building companies focused on developing novel medicines that address important unmet medical needs. read more

Houman Ashrafian

Houman joined SV in 2016 as a Venture Partner, was promoted to Partner in 2017, and became a Managing Partner in 2018. He has founded four SV companies, attracting strategic investment into three within 12 months at valuation uplifts. He is currently a Director of Enara Bio and TRexBio and serves on the Dementia Discovery Fund (DDF) Investment Committee. read more

Thomas Dyrberg

Thomas joined Novo A/S in 2000. He is Managing Partner of Novo Ventures and on the Leadership Team of Novo Holdings. He is a member of the Boards of Directors of Galera Therapeutics, Nuvelution Pharma, Ophthotech Corporation and PanOptica. read more